Evidence mapPaperPMID 35776376Full record

ArticleInternational journal of clinical pharmacy2022

Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review.

Mohammed Biset Ayalew, M Joy Spark, Frances Quirk, Gudrun Dieberg

Open access · hybridAbstract readScoping Review
In one paragraph

Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mohammed Biset AyalewPharmacy, School of Rural Medicine, University of New England, Armidale, NSW 2351, Australia.ORCID http://orcid.org/0000-0003-2468-7778
M Joy SparkPharmacy, School of Rural Medicine, University of New England, Armidale, NSW 2351, Australia.ORCID http://orcid.org/0000-0001-5240-8217
Frances QuirkSchool of Rural Medicine, University of New England, Armidale, NSW 2351, Australia.ORCID http://orcid.org/0000-0002-4177-0461
Gudrun DiebergBiomedical Science, School of Science and Technology, University of New England, Armidale, NSW 2351, Australia. gdieberg@une.edu.au.ORCID http://orcid.org/0000-0001-7191-182X
University of New England · AUUniversity of Gondar · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople living with diabetes often experience multiple morbidity and polypharmacy, increasing their risk of potentially inappropriate prescribing. Inappropriate prescribing is associated with poorer health outcomes.

aimThe aim of this scoping review was to explore and map studies conducted on potentially inappropriate prescribing among adults living with diabetes and to identify gaps regarding identification and assessment of potentially inappropriate prescribing in this group.

methodStudies that reported any type of potentially inappropriate prescribing were included. Studies conducted on people aged < 18 years or with a diagnosis of gestational diabetes or prediabetes were excluded. No restrictions to language, study design, publication status, geographic area, or clinical setting were applied in selecting the studies. Articles were systematically searched from 11 databases.

resultsOf the 190 included studies, the majority (63.7%) were conducted in high-income countries. None of the studies used an explicit tool specifically designed to identify potentially inappropriate prescribing among people with diabetes. The most frequently studied potentially inappropriate prescribing in high-income countries was contraindication while in low- and middle-income countries prescribing omission was the most common. Software and websites were mostly used for identifying drug-drug interactions. The specific events and conditions that were considered as inappropriate were inconsistent across studies.

conclusionContraindications, prescribing omissions and dosing problems were the most commonly studied types of potentially inappropriate prescribing. Prescribers should carefully consider the individual prescribing recommendations of medications. Future studies focusing on the development of explicit tools to identify potentially inappropriate prescribing for adults living with diabetes are needed.

Indexed as

Diabetes MellitusInappropriate PrescribingAdultDatabases, FactualDrug InteractionsHumansPolypharmacyPotentially Inappropriate Medication ListContraindicationsDiabetes mellitusInappropriate prescribingOmissionsScoping review

Identifiers

PMID35776376
PMCPMC9393152
OpenAlexW4283761951

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.